Giovanna D'Andrea Selected Research

Thrombomodulin

10/2022

Identification of the Novel G250R Variant Indicates a Role for Thrombomodulin in Modulating the Risk for Venous Thromboembolism.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Giovanna D'Andrea Research Topics

Disease

7	Thrombosis (Thrombus) 03/2024 - 01/2002
4	Venous Thromboembolism 10/2022 - 10/2018
3	Hypertension (High Blood Pressure) 06/2023 - 09/2021
2	Ischemic Stroke 08/2022 - 10/2018
2	Neoplasms (Cancer) 06/2022 - 01/2014
2	Venous Thrombosis (Deep-Vein Thrombosis) 01/2021 - 04/2003
2	Protein S Deficiency (Deficiency, Protein S) 01/2018 - 04/2003
2	Activated Protein C Resistance (APC Resistance) 01/2018 - 03/2003
2	Phenylketonurias (Phenylketonuria) 02/2014 - 12/2013
1	Dmd-Associated Dilated Cardiomyopathy 02/2024
1	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 02/2024
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 02/2024
1	Muscular Diseases (Myopathy) 02/2024
1	Retinal Vein Occlusion 01/2024
1	Obesity 06/2023
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2023
1	Liver Diseases (Liver Disease) 01/2023
1	Migraine Disorders (Migraine) 08/2022
1	Heart Failure 01/2022
1	Angioedema 05/2021
1	Hereditary Angioedemas 05/2021
1	Hemorrhage 11/2020
1	Atherosclerosis 10/2018
1	Myocardial Infarction 10/2018
1	Peripheral Vascular Diseases (Peripheral Vascular Disease) 10/2018
1	Atrial Fibrillation 08/2016
1	Malnutrition (Nutritional Deficiencies) 10/2015
1	Infections 10/2014
1	Chronic Hepatitis (Chronic Active Hepatitis) 01/2014
1	Vasculitis (Vasculitides) 01/2014
1	Hemophilia A (Haemophilia) 10/2009
1	Thrombasthenia (Glanzmann Thrombasthenia) 10/2008
1	Thrombophilia 04/2003

Drug/Important Bio-Agent (IBA)

5	Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA 03/2024 - 08/2022
4	HomocysteineIBA 03/2024 - 09/2021
4	AnticoagulantsIBA 01/2023 - 08/2016
4	factor V LeidenIBA 01/2021 - 01/2002
3	Prothrombin (Factor II)IBA 03/2024 - 01/2021
3	Protein CIBA 01/2023 - 01/2002
3	Factor V (Coagulation Factor V)IBA 01/2021 - 01/2002
2	EnzymesIBA 09/2021 - 05/2021
2	Protein SIBA 01/2021 - 04/2003
2	Ribavirin (Virazole)FDA LinkGeneric 10/2014 - 01/2014
2	InterferonsIBA 10/2014 - 01/2014
2	Phenylalanine Hydroxylase (Phenylalanine 4 Monooxygenase)IBA 02/2014 - 12/2013
1	DystrophinIBA 02/2024
1	ThrombomodulinIBA 10/2022
1	Fumigant 93 (D-D)IBA 06/2022
1	Interleukin-6 (Interleukin 6)IBA 01/2022
1	CytokinesIBA 01/2022
1	Oxidoreductases (Dehydrogenase)IBA 09/2021
1	BradykininIBA 05/2021
1	Complement C1 Inhibitor Protein (C1 Esterase Inhibitor)IBA 05/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	AntithrombinsIBA 01/2021
1	CoagulantsIBA 01/2021
1	oxidized low density lipoproteinIBA 10/2018
1	LipidsIBA 10/2018
1	Glycoproteins (Glycoprotein)IBA 10/2018
1	N 30IBA 10/2018
1	Fibrinogen (Factor I)FDA Link 01/2018
1	Dabigatran FDA Link 08/2016
1	Antiviral Agents (Antivirals)IBA 01/2014
1	InterleukinsIBA 01/2014
1	Platelet Glycoprotein GPIIb-IIIa ComplexIBA 10/2008
1	Integrin beta3 (GPIIIa)IBA 10/2008
1	Amino Acids FDA Link 10/2008
1	AntigensIBA 04/2003

Therapy/Procedure

5	Therapeutics 11/2020 - 01/2014
1	Ligation 10/2009